A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: Is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples?

被引:34
作者
Castilloux, Jean Francois
Moffat, Karen A. [2 ,3 ]
Liu, Yang [2 ]
Seecharan, Jodi [3 ]
Pai, Menaka [2 ,3 ]
Hayward, Catherine P. M. [1 ,2 ,3 ]
机构
[1] McMaster Univ, Hlth Sci Ctr, Dept Pathol & Mol Med, Hamilton, ON L8S 4K1, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada
[3] McMaster Univ, Program Med, Hamilton Reg Lab, Hamilton, ON L8S 4K1, Canada
关键词
Clinical studies; platelet disorders; platelet pathology; inherited; acquired; DIAGNOSTIC-ASSESSMENT; AGGREGATION; AREAS;
D O I
10.1160/TH11-06-0378
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Light transmission platelet aggregometry (LTA) is important to diagnose bleeding disorders. Experts recommend testing LTA with native (N) rather than platelet count adjusted (A) platelet-rich plasma (PRP), although it is unclear if this provides non-inferior, or superior, detection of bleeding disorders. Our goal was to determine if LTA with NPRP is non-inferior to LTA with APRP for bleeding disorder assessments. A prospective cohort of patients, referred for bleeding disorder testing, and healthy controls, were evaluated by LTA using common agonists, N PRP and APRP (adjusted to 250 x 109 platelets/I). Recruitment continued until 40 controls and 40 patients with definite bleeding disorders were tested. Maximal aggregation (MA) data were assessed for the detection of abnormalities from bleeding disorders (all causes combined to limit bias), using sample-type specific reference intervals. Areas under receiver-operator curves (AUROC) were evaluated using pre-defined criteria (area differences: <0.15 for non-inferiority, >0 for superiority). Forty-four controls and 209 patients were evaluated. Chart reviews for 169 patients indicated 67 had bleeding disorders, 28 from inherited platelet secretion defects. Mean MA differences between N PRP and APRP were small for most agonists (ranges, controls: -3.3 to 5.8; patients: -3.0 to 13.7). With both samples, reduced MA with two or more agonists was associated with a bleeding disorder. AUROC differences between NPRP and APRP were small and indicated that NPRP were non-inferior to APRP for detecting bleeding disorders by LTA, whereas APRP met superiority criteria. Our study validates using either N PRP or APRP for LTA assessments of bleeding disorders.
引用
收藏
页码:675 / 682
页数:8
相关论文
共 21 条
[11]   Diagnostic evaluation of platelet function disorders [J].
Hayward, Catherine P. M. .
BLOOD REVIEWS, 2011, 25 (04) :169-173
[12]   Development of North American Consensus Guidelines for Medical Laboratories That Perform and Interpret Platelet Function Testing Using Light Transmission Aggregometry [J].
Hayward, Catherine P. M. ;
Moffat, Karen A. ;
Raby, Anne ;
Israels, Sara ;
Plumhoff, Elizabeth ;
Flynn, Greg ;
Zehnder, James L. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (06) :955-963
[13]   A non-inferiority test for diagnostic accuracy based on the paired partial areas under ROC curves [J].
Li, Chi-Rong ;
Liao, Chen-Tuo ;
Liu, Jen-Pei .
STATISTICS IN MEDICINE, 2008, 27 (10) :1762-1776
[14]   Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary [J].
Linnemann, B. ;
Schwonberg, J. ;
Mani, H. ;
Prochnow, S. ;
Lindhoff-Last, E. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (04) :677-683
[15]   Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements [J].
Mani, H ;
Luxembourg, B ;
Kläffling, C ;
Erbe, M ;
Lindhoff-Last, E .
JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (07) :747-750
[16]   The Level of Laboratory Testing Required for Diagnosis or Exclusion of a Platelet Function Disorder Using Platelet Aggregation and Secretion Assays [J].
Mezzano, Diego ;
Quiroga, Teresa ;
Pereira, Jaime .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (02) :242-254
[17]   Diagnostic Assessment of Platelet Disorders: What Are the Challenges to Standardization? [J].
Pai, Menaka ;
Hayward, Catherine P. M. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (02) :131-138
[18]   Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene [J].
Paterson, Andrew D. ;
Rommens, Johanna M. ;
Bharaj, Bhupinder ;
Blavignac, Jessica ;
Wong, Isidro ;
Diamandis, Maria ;
Waye, John S. ;
Rivard, Georges E. ;
Hayward, Catherine P. M. .
BLOOD, 2010, 115 (06) :1264-1266
[19]   Reporting of noninferiority and equivalence randomized trials - An extension of the CONSORT Statement [J].
Piaggio, G ;
Elbourne, DR ;
Altman, DG ;
Pocock, SJ ;
Evans, SJW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (10) :1152-1160
[20]   Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays [J].
Quiroga, Teresa ;
Goycoolea, Manuela ;
Matus, Valeria ;
Zuniga, Pamela ;
Martinez, Carlos ;
Garrido, Marcelo ;
Aranda, Eduardo ;
Leighton, Federico ;
Panes, Olga ;
Pereira, Jaime ;
Mezzano, Diego .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (05) :729-736